Pharmaceutical News

RSS

Groundbreaking study finds certain brain disorders are genetically related

A large-scale, global study conducted by the Brainstorm Consortium has shown that certain brain disorders are genetically related.

22 Aug 2018

Simple paper-based test identifies falsified and substandard antibiotics

Antibiotics - medicines that treat bacterial infections - have saved millions of lives worldwide since their discovery in the early 20th century.

22 Aug 2018

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.

22 Aug 2018

Researchers explore use of antipsychotic medications in older adults following heart surgery

Delirium is the medical term for an abrupt, rapid change in mental function that goes well beyond the typical forgetfulness of aging.

21 Aug 2018

Study may fuel need for effective drug testing in hospital emergency departments

At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for the first time, highlights the complexity of detecting and treating patients at hospital emergency departments for a severe drug-related event.

21 Aug 2018

Scientists discover peptides that can be used as new antibiotic candidates

The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body can also have potent antimicrobial effects, expanding the pool of new antibiotic candidates.

21 Aug 2018

Research provides drug developers with much needed insight into serotonin receptor

Serotonin, known as the "happiness" neurotransmitter, is a chemical found in the body responsible for feelings of well-being. But serotonin isn't the only chemical that binds to the 13 serotonin receptors found on the surface of cells. Far from it. Many approved drugs also bind to serotonin receptors.

21 Aug 2018

RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits

RxBenefits, a full-service pharmacy benefits advisory firm, is pleased to introduce its latest innovation, a tailored and flexible approach to managing hospital pharmacy benefits.

21 Aug 2018

New proposal aims to improve drug harm assessment process

A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.

20 Aug 2018

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain.

20 Aug 2018

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

URI professor develops simpler and quicker method for detecting impurity in heparin

In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply of the popular blood thinner heparin, sickening hundreds and killing about 100 in the U.S.

19 Aug 2018

AJMC addresses role of community pharmacies in boosting adult vaccination rates

A recent publication from The American Journal of Managed Care, the leading peer-reviewed journal dedicated to issues in managed care, addresses the role of community pharmacies in boosting adult vaccination rates in the United States.

17 Aug 2018

New statewide program in North Dakota aims to stem opioid misuse

Preliminary estimates released by the U.S. Centers for Disease Control and Prevention show a nearly 7 percent increase in drug overdoses in 2017, with more than 72,000 deaths. Of the total deaths, almost 68 percent of them were tied to opioid use. A new statewide program in North Dakota called ONE Rx aims to stem opioid misuse by increasing awareness when patients first fill an opioid prescription.

17 Aug 2018

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

Medicaid expansion under the Affordable Care Act (ACA) was associated with an overall increase in people filling prescriptions for buprenorphine with naloxone, which is a treatment for opioid use disorder, as well as an increase in people filling prescriptions for opioid pain relievers (OPRs) paid for by Medicaid in a data analysis from five states.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.

17 Aug 2018

Biomarker predicts kidney cancer risk years before diagnosis

Scientists have identified a blood biomarker that could be used to predict the onset of renal cell carcinoma (RCC) years before the disease is diagnosed.

17 Aug 2018

Pharmaceutical News

Groundbreaking study finds certain brain disorders are genetically related

Simple paper-based test identifies falsified and substandard antibiotics

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Researchers explore use of antipsychotic medications in older adults following heart surgery

Study may fuel need for effective drug testing in hospital emergency departments

Scientists discover peptides that can be used as new antibiotic candidates

Research provides drug developers with much needed insight into serotonin receptor

RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits

New proposal aims to improve drug harm assessment process

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Unique pain program helps surgical patients wean off opioids safely and effectively

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

URI professor develops simpler and quicker method for detecting impurity in heparin

AJMC addresses role of community pharmacies in boosting adult vaccination rates

New statewide program in North Dakota aims to stem opioid misuse

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Biomarker predicts kidney cancer risk years before diagnosis

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News